Bluebird Net Income Per Share vs Ev To Sales Analysis

BLUE Stock  USD 0.38  0.01  2.56%   
Bluebird Bio financial indicator trend analysis is way more than just evaluating Bluebird bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bluebird bio is a good investment. Please check the relationship between Bluebird Bio Net Income Per Share and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Net Income Per Share vs Ev To Sales

Net Income Per Share vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bluebird bio Net Income Per Share account and Ev To Sales. At this time, the significance of the direction appears to have weak relationship.
The correlation between Bluebird Bio's Net Income Per Share and Ev To Sales is 0.39. Overlapping area represents the amount of variation of Net Income Per Share that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Bluebird bio, assuming nothing else is changed. The correlation between historical values of Bluebird Bio's Net Income Per Share and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income Per Share of Bluebird bio are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Net Income Per Share i.e., Bluebird Bio's Net Income Per Share and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.39
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Income Per Share

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.
Most indicators from Bluebird Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bluebird bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.At present, Bluebird Bio's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 386.4 M, whereas Tax Provision is projected to grow to (119.7 K).
 2021 2022 2023 2024 (projected)
Total Operating Expenses529.9M275.7M273.8M373.9M
Cost Of Revenue38.9M10.1M33.5M36.1M

Bluebird Bio fundamental ratios Correlations

0.710.640.960.70.740.56-0.42-0.240.560.780.870.610.60.950.550.130.920.640.380.540.690.690.95-0.070.45
0.710.770.680.470.760.31-0.17-0.410.660.360.680.820.810.70.560.010.790.560.710.560.720.720.69-0.150.37
0.640.770.510.260.910.140.16-0.790.850.370.730.970.980.510.890.540.550.720.450.890.930.920.530.420.8
0.960.680.510.790.60.67-0.61-0.020.450.780.80.470.460.990.44-0.130.950.510.360.330.550.550.98-0.290.24
0.70.470.260.790.360.62-0.50.260.240.450.650.230.220.730.18-0.350.820.260.39-0.010.280.30.72-0.39-0.03
0.740.760.910.60.360.150.13-0.70.730.430.810.920.920.590.820.460.640.910.480.830.981.00.620.390.75
0.560.310.140.670.620.15-0.780.290.140.710.290.030.030.710.12-0.330.57-0.030.05-0.080.060.10.68-0.48-0.05
-0.42-0.170.16-0.61-0.50.13-0.78-0.570.08-0.7-0.030.230.24-0.630.140.62-0.470.22-0.040.360.20.18-0.650.710.37
-0.24-0.41-0.79-0.020.26-0.70.29-0.57-0.61-0.06-0.43-0.8-0.8-0.03-0.82-0.82-0.03-0.58-0.23-0.95-0.74-0.74-0.04-0.79-0.92
0.560.660.850.450.240.730.140.08-0.610.30.630.860.860.460.680.350.510.560.10.70.760.730.460.310.6
0.780.360.370.780.450.430.71-0.7-0.060.30.430.260.260.790.40.080.580.330.130.320.380.40.85-0.110.33
0.870.680.730.80.650.810.29-0.03-0.430.630.430.730.720.750.670.280.830.730.350.660.790.780.720.180.58
0.610.820.970.470.230.920.030.23-0.80.860.260.731.00.470.840.470.560.750.490.880.930.930.480.40.75
0.60.810.980.460.220.920.030.24-0.80.860.260.721.00.460.850.490.540.750.480.880.940.930.470.410.76
0.950.70.510.990.730.590.71-0.63-0.030.460.790.750.470.460.41-0.130.940.50.350.330.550.540.98-0.330.21
0.550.560.890.440.180.820.120.14-0.820.680.40.670.840.850.410.550.390.620.30.880.820.850.440.570.89
0.130.010.54-0.13-0.350.46-0.330.62-0.820.350.080.280.470.49-0.130.55-0.170.460.010.780.540.51-0.090.860.82
0.920.790.550.950.820.640.57-0.47-0.030.510.580.830.560.540.940.39-0.170.550.490.320.590.580.91-0.340.17
0.640.560.720.510.260.91-0.030.22-0.580.560.330.730.750.750.50.620.460.550.340.70.920.910.520.390.6
0.380.710.450.360.390.480.05-0.04-0.230.10.130.350.490.480.350.30.010.490.340.310.420.450.38-0.150.2
0.540.560.890.33-0.010.83-0.080.36-0.950.70.320.660.880.880.330.880.780.320.70.310.860.860.350.680.95
0.690.720.930.550.280.980.060.2-0.740.760.380.790.930.940.550.820.540.590.920.420.860.990.560.430.76
0.690.720.920.550.31.00.10.18-0.740.730.40.780.930.930.540.850.510.580.910.450.860.990.570.440.78
0.950.690.530.980.720.620.68-0.65-0.040.460.850.720.480.470.980.44-0.090.910.520.380.350.560.57-0.290.25
-0.07-0.150.42-0.29-0.390.39-0.480.71-0.790.31-0.110.180.40.41-0.330.570.86-0.340.39-0.150.680.430.44-0.290.8
0.450.370.80.24-0.030.75-0.050.37-0.920.60.330.580.750.760.210.890.820.170.60.20.950.760.780.250.8
Click cells to compare fundamentals

Bluebird Bio Account Relationship Matchups

Bluebird Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.7B1.8B593.8M554.9M619.2M1.1B
Other Current Liab141.6M180.1M78.5M52.0M9.0M8.6M
Total Current Liabilities223.6M203.6M153.0M128.2M200.1M114.3M
Total Stockholder Equity1.3B1.4B374.3M196.3M194.5M184.8M
Other Liab58.0M48.0M54.6M93K107.0K101.6K
Property Plant And Equipment Net337.1M346.9M101.2M291.4M267.0M174.1M
Current Deferred Revenue18.9M11.6M2.3M1.5M1.4M1.3M
Net Debt(136.2M)(124.7M)(71.6M)168.4M193.6M203.3M
Retained Earnings(2.3B)(2.9B)(3.7B)(4.0B)(4.3B)(4.0B)
Accounts Payable43.0M13.8M25.9M14.9M18.5M15.1M
Cash327.2M317.7M161.2M113.0M221.8M287.0M
Non Current Assets Total575.3M565.7M257.3M355.4M337.5M352.4M
Non Currrent Assets Other79.2M72.8M53.3M52.1M54.3M35.0M
Other Assets79.2M72.8M53.3M52.1M59.9M33.2M
Cash And Short Term Investments1.2B1.3B396.6M181.7M209.0M198.6M
Common Stock Total Equity547K554K665K711K817.7K431.4K
Common Stock Shares Outstanding55.2M62.2M68.9M78.6M192.8M202.4M
Short Term Investments531.6M982.7M779.2M833.5M138.3M67.3M
Liabilities And Stockholders Equity1.7B1.8B593.8M554.9M638.1M1.1B
Non Current Liabilities Total218.9M222.6M66.5M230.3M224.5M161.3M
Other Current Assets45.7M522.2M25.6M8.6M9.9M9.4M
Other Stockholder Equity3.6B4.3B4.1B4.2B4.8B5.1B
Total Liab442.4M426.2M219.5M358.6M424.6M275.6M
Property Plant And Equipment Gross337.1M346.9M121.6M313.3M308.9M181.3M
Total Current Assets1.2B1.2B336.5M199.5M281.7M267.6M
Accumulated Other Comprehensive Income(1.9M)(5.5M)(2.9M)(4.1M)(3.7M)(3.8M)
Short Term Debt20.2M9.7M46.3M88.2M101.5M106.6M
Common Stock554K665K711K830K954.5K1.0M
Property Plant Equipment151.2M162.8M101.2M291.4M335.1M351.8M
Net Tangible Assets1.3B1.3B368.6M185.8M213.7M203.0M
Net Receivables12.8M2.4M11.4M10.8M22.2M23.3M
Retained Earnings Total Equity(1.5B)(2.3B)(2.9B)(3.7B)(3.3B)(3.2B)
Capital Surpluse3.4B3.6B4.3B4.1B4.7B2.6B
Inventory(144.3M)(149.7M)(108.5M)(1.4M)22.9M24.1M
Non Current Liabilities Other218.9M222.6M93K92K105.8K100.5K
Intangible Assets14.3M10.0M5.6M4.9M10.4M10.8M
Long Term Investments506.1M131.5M122.9M97.1M1.4M0.0

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(34.93)
Revenue Per Share
0.357
Quarterly Revenue Growth
1.337
Return On Assets
(0.36)
Return On Equity
(1.87)
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.